肠易激综合征的神经生物学
肠易激综合征是全球患病率5%–10%的脑-肠相互作用障碍,现行症状标准仅限反复腹痛伴排便习惯改变,但多数患者还报告非疼痛性腹部不适、焦虑抑郁及内脏和躯体疼痛症状。该综述整合脑-肠-微生物组互作的中心与外周机制及遗传因素,提出可解释排便习惯改变、慢性腹痛和精神共病的系统性疾病模型。
要点
- 肠易激综合征影响全球5%–10%的普通人群,是最常见的脑-肠相互作用障碍。
- 现行症状标准将诊断限于反复腹痛伴排便习惯改变,但多数患者还报告非疼痛性腹部不适及焦虑抑郁。
- 综述提出脑-肠-微生物组互作的系统性疾病模型,可解释排便习惯改变、慢性腹痛和精神共病。
核心结论
- 基于脑-肠-微生物组互作的系统性疾病模型可解释肠易激综合征的排便习惯改变、慢性腹痛和精神共病。
研究设计与样本
- 综述整合了肠易激综合征症状病理生理学涉及的中心、外周机制及遗传因素的广泛已发表信息。
主要发现
- 肠易激综合征影响全球5%–10%的普通人群,是最常见的脑-肠相互作用障碍。
- 现行症状标准将诊断限于反复腹痛伴排便习惯改变,但多数患者还报告非疼痛性腹部不适、焦虑抑郁及内脏和躯体疼痛相关症状。
- 综述描述了肠道连接组和肠神经系统改变、 distinct 脑功能与结构特征,并与焦虑障碍中提出的脑改变进行比较。
- 综述指出了脑网络与基因组、胃肠道、免疫及肠道微生物组相关参数之间新出现的相关性。
临床怎么用
- 临床应超越现行症状标准,关注肠易激综合征患者的非疼痛性腹部不适、焦虑抑郁及内脏和躯体疼痛症状。
- 可将脑-肠-微生物组互作的系统性疾病模型用于理解肠易激综合征并指导开发更有效的治疗方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Irritable bowel syndrome (IBS) is the most prevalent disorder of brain-gut interactions that affects between 5 and 10% of the general population worldwide. The current symptom criteria restrict the diagnosis to recurrent abdominal pain associated with altered bowel habits, but the majority of patients also report non-painful abdominal discomfort, associated psychiatric conditions (anxiety and depression), as well as other visceral and somatic pain-related symptoms. For decades, IBS was considered an intestinal motility disorder, and more recently a gut disorder. However, based on an extensive body of reported information about central, peripheral mechanisms and genetic factors involved in the pathophysiology of IBS symptoms, a comprehensive disease model of brain-gut-microbiome interactions has emerged, which can explain altered bowel habits, chronic abdominal pain, and psychiatric comorbidities. In this review, we will first describe novel insights into several key components of brain-gut microbiome interactions, starting with reported alterations in the gut connectome and enteric nervous system, and a list of distinct functional and structural brain signatures, and comparing them to the proposed brain alterations in anxiety disorders. We will then point out the emerging correlations between the brain networks with the genomic, gastrointestinal, immune, and gut microbiome-related parameters. We will incorporate this new information into a systems-based disease model of IBS. Finally, we will discuss the implications of such a model for the improved understanding of the disorder and the development of more effective treatment approaches in the future.
引用
- Mayer EA, Ryu HJ, Bhatt RR, et al. The neurobiology of irritable bowel syndrome. Mol Psychiatry. 2023. PMID: 36732586. doi:10.1038/s41380-023-01972-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。